These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37562710)

  • 21. CSF total and oligomeric α-Synuclein along with TNF-α as risk biomarkers for Parkinson's disease: a study in LRRK2 mutation carriers.
    Majbour NK; Aasly JO; Hustad E; Thomas MA; Vaikath NN; Elkum N; van de Berg WDJ; Tokuda T; Mollenhauer B; Berendse HW; El-Agnaf OMA
    Transl Neurodegener; 2020 May; 9(1):15. PubMed ID: 32375873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glymphatic function assessment in Parkinson's disease using diffusion tensor image analysis along the perivascular space.
    Bae YJ; Kim JM; Choi BS; Choi JH; Ryoo N; Song YS; Cho SJ; Kim JH
    Parkinsonism Relat Disord; 2023 Sep; 114():105767. PubMed ID: 37523953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The severity assessment of Parkinson's disease based on plasma inflammatory factors and third ventricle width by transcranial sonography.
    Lu Y; Dong W; Xue X; Sun J; Yan J; Wei X; Chang L; Zhao L; Luo B; Qiu C; Zhang W
    CNS Neurosci Ther; 2024 Mar; 30(3):e14670. PubMed ID: 38459662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimating the sequence of biomarker changes in Parkinson's disease.
    Xiang Y; Huang X; Xu Q; Liu Z; Chen Y; Sun Q; Wang J; Jiang H; Shen L; Yan X; Tang B; Guo J
    Parkinsonism Relat Disord; 2024 Jan; 118():105939. PubMed ID: 38029648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation between blood pressure indexes and prognosis in sepsis patients: a cohort study based on MIMIC-III database].
    Liu X; Zhao Y; Qin Y; Ma Q; Wang Y; Weng Z; Zhu F
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jun; 35(6):578-585. PubMed ID: 37366122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The longitudinal progression of autonomic dysfunction in Parkinson's disease: A 7-year study.
    Stewart CB; Ledingham D; Foster VK; Anderson KN; Sathyanarayana S; Galley D; Pavese N; Pasquini J
    Front Neurol; 2023; 14():1155669. PubMed ID: 37122303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A nomogram incorporating functional and tubular damage biomarkers to predict the risk of acute kidney injury for septic patients.
    Ma J; Deng Y; Lao H; Ouyang X; Liang S; Wang Y; Yao F; Deng Y; Chen C
    BMC Nephrol; 2021 May; 22(1):176. PubMed ID: 33985459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Establishment and validation of a novel nomogram to predict overall survival after radical nephrectomy].
    Xiong LB; Zou XP; Ning K; Luo X; Peng YL; Zhou ZH; Wang J; Li Z; Yu CP; Dong P; Guo SJ; Han H; Zhou FJ; Zhang ZL
    Zhonghua Zhong Liu Za Zhi; 2023 Aug; 45(8):681-689. PubMed ID: 37580273
    [No Abstract]   [Full Text] [Related]  

  • 30. Trajectory Analysis of Orthostatic Hypotension in Parkinson's Disease: Results From Parkinson's Progression Markers Initiative Cohort.
    Chen K; Du K; Zhao Y; Gu Y; Zhao Y
    Front Aging Neurosci; 2021; 13():762759. PubMed ID: 34987376
    [No Abstract]   [Full Text] [Related]  

  • 31. Noninvasive neuroimaging provides evidence for deterioration of the glymphatic system in Parkinson's disease relative to essential tremor.
    Gu L; Dai S; Guo T; Si X; Lv D; Wang Z; Lu J; Fang Y; Guan X; Zhou C; Wu H; Xu X; Yan Y; Song Z; Zhang MM; Zhang B; Pu J
    Parkinsonism Relat Disord; 2023 Feb; 107():105254. PubMed ID: 36584484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.
    Kang JH; Irwin DJ; Chen-Plotkin AS; Siderowf A; Caspell C; Coffey CS; Waligórska T; Taylor P; Pan S; Frasier M; Marek K; Kieburtz K; Jennings D; Simuni T; Tanner CM; Singleton A; Toga AW; Chowdhury S; Mollenhauer B; Trojanowski JQ; Shaw LM;
    JAMA Neurol; 2013 Oct; 70(10):1277-87. PubMed ID: 23979011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting the multi-domain progression of Parkinson's disease: a Bayesian multivariate generalized linear mixed-effect model.
    Wang M; Li Z; Lee EY; Lewis MM; Zhang L; Sterling NW; Wagner D; Eslinger P; Du G; Huang X
    BMC Med Res Methodol; 2017 Sep; 17(1):147. PubMed ID: 28946857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nomogram to predict the progression of patients with primary membranous nephropathy and nephrotic syndrome.
    Liu L; Wang H; Zhao B; Liu X; Sun Y; Mao Y
    Int Urol Nephrol; 2022 Feb; 54(2):331-341. PubMed ID: 33909236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictive Big Data Analytics: A Study of Parkinson's Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations.
    Dinov ID; Heavner B; Tang M; Glusman G; Chard K; Darcy M; Madduri R; Pa J; Spino C; Kesselman C; Foster I; Deutsch EW; Price ND; Van Horn JD; Ames J; Clark K; Hood L; Hampstead BM; Dauer W; Toga AW
    PLoS One; 2016; 11(8):e0157077. PubMed ID: 27494614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nomogram to Predict Cognitive State Improvement after Deep Brain Stimulation for Parkinson's Disease.
    Chang B; Ni C; Zhang W; Mei J; Xiong C; Chen P; Jiang M; Niu C
    Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
    Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
    Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and Validation of an MRI-Based Nomogram Model for Predicting Disease-Free Survival in Locally Advanced Rectal Cancer Treated With Neoadjuvant Radiotherapy.
    Chen S; Tang Y; Li N; Jiang J; Jiang L; Chen B; Fang H; Qi S; Hao J; Lu N; Wang S; Song Y; Liu Y; Li Y; Jin J
    Front Oncol; 2021; 11():784156. PubMed ID: 34869040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Motor progression marker for newly diagnosed drug-naïve patients with Parkinson's disease: A resting-state functional MRI study.
    Hou Y; Zhang L; Ou R; Wei Q; Gu X; Liu K; Lin J; Yang T; Xiao Y; Gong Q; Shang H
    Hum Brain Mapp; 2023 Feb; 44(3):901-913. PubMed ID: 36250699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffusion Tensor Imaging Along the Perivascular Space Index in Different Stages of Parkinson's Disease.
    Ma X; Li S; Li C; Wang R; Chen M; Chen H; Su W
    Front Aging Neurosci; 2021; 13():773951. PubMed ID: 34867300
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.